Evidence map›Paper›PMID 38543318›Full record

ArticlePharmaceutics2024

Novel Fluorescent Strategy for Discriminating T and B Lymphocytes Using Transport System.

Heewon Cho, Na-Kyeong Hong, Young-Tae Chang

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Heewon ChoDepartment of Chemistry, Pohang University of Science and Technology (POSTECH), Pohang 37673, Gyeongsangbuk-do, Republic of Korea.
Na-Kyeong HongDepartment of Chemistry, Pohang University of Science and Technology (POSTECH), Pohang 37673, Gyeongsangbuk-do, Republic of Korea.
Young-Tae ChangDepartment of Chemistry, Pohang University of Science and Technology (POSTECH), Pohang 37673, Gyeongsangbuk-do, Republic of Korea.ORCID 0000-0002-1927-3688
Pohang University of Science and Technology · KR

Funding

Basic Science Research Institute Fund 2021R1A6A1A10042944Institute for Basic Science IBS-R007-A1National Research Foundation of Korea 2023R1A2C300453411
6 · The paper itself

Abstract

Fluorescent bioprobes are invaluable tools for visualizing live cells and deciphering complex biological processes by targeting intracellular biomarkers without disrupting cellular functions. In addition to protein-binding concepts, fluorescent probes utilize various mechanisms, including membrane, metabolism, and gating-oriented strategies. This study introduces a novel fluorescent mechanism distinct from existing ways. Here, we developed a B cell selective probe, CDrB, with unique transport mechanisms. Through SLC-CRISPRa screening, we identified two transporters, SLCO1B3 and SLC25A41, by sorting out populations exhibiting higher and lower fluorescence intensities, respectively, demonstrating contrasting activities. We confirmed that SLCO1B3, with comparable expression levels in T and B cells, facilitates the transport of CDrB into cells, while SLC25A41, overexpressed in T lymphocytes, actively exports CDrB. This observation suggests that SLC25A41 plays a crucial role in discriminating between T and B lymphocytes. Furthermore, it reveals the potential for the reversible localization of SLC25A41 to demonstrate its distinct activity. This study is the first report to unveil a novel strategy of SLC by exporting the probe. We anticipate that this research will open up new avenues for developing fluorescent probes.

Indexed as

B cell-specific probefluorescent carbohydrate librarygating-oriented live-cell distinctionhigh-throughput phenotypic screeningsolute carrier

Identifiers

PMID38543318
PMCPMC10974409
OpenAlexW4392952327

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.